What Happens After the Device IPO?
This article was originally published in Start Up
Executive Summary
Investors love to remind everyone that IPOs are financing events, not exiting events, using the mantra to put off Judgment Day for their investments. So how have device companies fared after the recent spate of IPOs?
You may also be interested in...
Can a Hippo Save the IPO Market for Life Sciences?
A group of private enterprises are working to revive the moribund IPO market for venture-backed start-ups.
Covidien Set to Compete in Vascular Business
Covidien, following the acquisition of Vnus Medical Technologies and Bacchus Vascular, is establishing a global business unit focused on vascular surgery.
Northstar Goes Supernova: Troubled Brain Stimulation Firm Plans Liquidation
The directors of Northstar Neuroscience, developer of the Renova cortical stimulation system, have elected to liquidate all assets and dissolve the company